Keybanc Maintains Overweight on ICU Medical, Raises Price Target to $147
Portfolio Pulse from Benzinga Newsdesk
Keybanc analyst Brett Fishbin maintains an Overweight rating on ICU Medical (NASDAQ:ICUI) and raises the price target from $136 to $147.
August 08, 2024 | 5:26 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Keybanc analyst Brett Fishbin maintains an Overweight rating on ICU Medical and raises the price target from $136 to $147.
The Overweight rating and increased price target from a reputable analyst at Keybanc is likely to positively influence investor sentiment and drive short-term price appreciation for ICU Medical.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100